These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14747141)

  • 1. Meeting report: the molecular background of severe and complicated malaria.
    Winter G; Chen Q; Wahlgren M
    Mol Biochem Parasitol; 2004 Mar; 134(1):37-41. PubMed ID: 14747141
    [No Abstract]   [Full Text] [Related]  

  • 2. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
    Saul A
    J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
    Ballou WR; Kester KE; Heppner DG
    Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
    [No Abstract]   [Full Text] [Related]  

  • 4. Malaria. How the parasite disguises itself.
    Nowak R
    Science; 1995 Aug; 269(5225):755. PubMed ID: 7638584
    [No Abstract]   [Full Text] [Related]  

  • 5. The development of a multivalent DNA vaccine for malaria.
    Hedstrom RC; Doolan DL; Wang R; Gardner MJ; Kumar A; Sedegah M; Gramzinski RA; Sacci JB; Charoenvit Y; Weiss WR; Margalith M; Norman JA; Hobart P; Hoffman SL
    Springer Semin Immunopathol; 1997; 19(2):147-59. PubMed ID: 9406343
    [No Abstract]   [Full Text] [Related]  

  • 6. Parasite variation provides hope for malaria vaccine design.
    Taylor-Robinson A
    Trends Microbiol; 2001 Apr; 9(4):157-8. PubMed ID: 11286867
    [No Abstract]   [Full Text] [Related]  

  • 7. Geographical distribution of a variant epitope of Pfs48/45, a Plasmodium falciparum transmission-blocking vaccine candidate.
    Drakeley CJ; Duraisingh MT; PĆ³voa M; Conway DJ; Targett GA; Baker DA
    Mol Biochem Parasitol; 1996 Oct; 81(2):253-7. PubMed ID: 8898341
    [No Abstract]   [Full Text] [Related]  

  • 8. Pfs230: from malaria transmission-blocking vaccine candidate toward function.
    Williamson KC
    Parasite Immunol; 2003 Jul; 25(7):351-9. PubMed ID: 14521577
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimal variation in the Pfs28 ookinete antigen from Philippine field isolates of Plasmodium falciparum.
    Hafalla JC; Santiago ML; Pasay MC; Ramirez BL; Gozar MM; Saul A; Kaslow DC
    Mol Biochem Parasitol; 1997 Jul; 87(1):97-9. PubMed ID: 9233677
    [No Abstract]   [Full Text] [Related]  

  • 10. Variant surface antigens of Plasmodium falciparum and their roles in severe malaria.
    Wahlgren M; Goel S; Akhouri RR
    Nat Rev Microbiol; 2017 Aug; 15(8):479-491. PubMed ID: 28603279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant antigens of Plasmodium falciparum encoded by the var multigenic family are multifunctional macromolecules.
    Nogueira PA; Wunderlich G; Pereira da Silva LH
    Res Microbiol; 2001 Mar; 152(2):141-7. PubMed ID: 11316367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinating with the genome: a Sisyphean task?
    Coppel RL
    Trends Parasitol; 2009 May; 25(5):205-12. PubMed ID: 19359219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. var genes, PfEMP1 and the human host.
    Flick K; Chen Q
    Mol Biochem Parasitol; 2004 Mar; 134(1):3-9. PubMed ID: 14747137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175.
    Liang H; Sim BK
    Mol Biochem Parasitol; 1997 Feb; 84(2):241-5. PubMed ID: 9084043
    [No Abstract]   [Full Text] [Related]  

  • 15. Theoretical immunology: parasitic turncoat.
    Antia R; Koella J
    Nature; 2004 Jun; 429(6991):511-3. PubMed ID: 15175734
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family.
    Kyes SA; Kraemer SM; Smith JD
    Eukaryot Cell; 2007 Sep; 6(9):1511-20. PubMed ID: 17644655
    [No Abstract]   [Full Text] [Related]  

  • 17. Variant surface antigens, virulence genes and the pathogenesis of malaria.
    Deitsch KW; Hviid L
    Trends Parasitol; 2004 Dec; 20(12):562-6. PubMed ID: 15522665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigens cross reactive with Plasmodium falciparum merozoite surface protein 4 are found in pre-erythrocytic and sexual stages.
    Wang L; Menting JG; Stowers A; Charoenvit Y; Sacci JB; Coppel RL
    Mol Biochem Parasitol; 2000 Jul; 109(2):189-94. PubMed ID: 10960179
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The varieties of gene amplification, diversification and hypervariability in the human malaria parasite, Plasmodium falciparum.
    Templeton TJ
    Mol Biochem Parasitol; 2009 Aug; 166(2):109-16. PubMed ID: 19375460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.